Therefore, on the one, PI3K/AKT signaling pathway was indeed involved in lung cancer development, and on the other its suppression might be an importantly promising target for juglanin against lung cancer progression in vitro and in vivo. This evidence concerns the gene AKT1 and lung carcinoma.